Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Brain-derived neurotrophic factor and its clinical implications.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Risk factors for idiopathic optic neuritis recurrence.
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis.
Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial.
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.
A PheWAS approach in studying HLA-DRB1*1501.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results.
Diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging, and two-dimensional navigator-based reacquisition in detecting acute optic neuritis.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
[Neuropathology of multiple sclerosis].
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Transglutaminase 2 and neuroinflammation.

Pages